Nocardiosis in Fish: Granulomatous Disease That Mimics Fish TB

Nocardia bacteria cause chronic nodular disease in the gills, skin, and internal organs of fish that can be mistaken for mycobacteriosis. Learn the signs, why treatment is difficult, and how to manage outbreaks.

Nocardiosis is a chronic bacterial disease of fish caused by Nocardia species, most notably Nocardia seriolae, which has become an important pathogen in both marine and freshwater aquaculture across Asia and beyond, affecting species such as yellowtail, amberjack, kingfish, largemouth bass, and golden pompano. Because it produces the same kind of nodular, granulomatous lesions as mycobacteriosis ('fish TB'), the two diseases are easily confused without laboratory testing.

Cause

Nocardia are gram-positive, branching, filamentous aerobic bacteria (actinomycetes) that are partially acid-fast, environmental saprophytes capable of opportunistic infection, per the Merck Veterinary Manual. Nocardia seriolae is considered an intracellular pathogen: genomic analysis shows it survives and multiplies inside host phagocytes — the very immune cells meant to destroy it — which is a major reason the infection is so difficult to clear.

Clinical signs

Outbreaks in farmed fish have been documented with the following gross and microscopic findings:

Nodules or tubercles of varying size in the gills, spleen, kidney, and liver
Skin ulcers and hemorrhage
On histology: necrotizing granulomatous inflammation of the liver, kidney, and spleen, along with gill epithelial hypertrophy and hyperplasia, as documented in an outbreak investigation in farmed largemouth bass
Outbreaks have caused significant mortality and economic loss in affected aquaculture operations, though the exact toll varies by species, facility, and outbreak

Diagnosis

A firm diagnosis relies on bacterial culture, Gram staining to reveal the characteristic branching filaments, a modified Ziehl-Neelsen (partial acid-fast) stain, and molecular identification such as 16S rRNA or hsp65 gene sequencing to confirm the species. This should be performed by a fish-health veterinarian or aquatic diagnostic laboratory rather than assumed from external signs alone.

Treatment and prognosis

Nocardiosis is generally described as refractory to conventional antibiotic therapy, in part because the bacteria survive inside host cells and can carry multiple natural antibiotic-resistance mechanisms, per genomic analysis of N. seriolae. In some aquaculture settings, sulfonamide-class antibiotics have regulatory approval for use against N. seriolae, but treatment courses are long, outcomes are inconsistent, and antibiotic resistance is a recognized concern.

Prevention and management

Because treatment is unreliable, prevention and outbreak control matter most:

Minimize crowding and handling stress, which predispose fish to opportunistic infection
Maintain good water quality and reduce organic load, since Nocardia is an environmental organism that thrives in poor conditions
Quarantine new stock before introducing it to an established system
Promptly remove and isolate fish showing nodules, ulcers, or unexplained wasting
Disinfect nets, tanks, and equipment between systems, and avoid moving fish or water from an affected facility

Handling precautions

Nocardia species are opportunistic environmental bacteria that can, in rare cases, infect people — usually through wound contamination or inhalation, and mainly in individuals who are immunocompromised, per the Merck Veterinary Manual. As with any fish showing chronic nodular or wasting disease, wear gloves when handling sick fish or cleaning affected tanks, and keep any skin wounds covered.

Sources: www.merckvetmanual.com pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov pubmed.ncbi.nlm.nih.gov